// App-Quantinova.ai

: Biochemical recurrence (BCR) surrogacy for clinical outcomes after radiotherapy for adenocarcinoma of the prostate (BCRSCRAP): A meta-analysis from MARCAP Consortium.

Researchers

Presenter

  • Soumyajit Roy

Principal Investigators

  • Allison Steigler

  • James William Denham

  • David John Joseph

  • Jeff M. Michalski

  • Felix Y Feng

  • Michel Bolla

  • Theo M. de Reijke

  • Philippe Maingon

  • Matthew R. Sydes

  • David P. Dearnaley

  • Luca Incrocci

  • Wilma Heemsbergen

  • Abdenour Nabid

  • Luis Souhami

  • Almudena Zapatero

  • Yilun Sun

  • Daniel Eidelberg Spratt

  • Amar Upadhyaya Kishan

Medical Centers

  • University of Amsterdam, Amsterdam, Netherlands

  • Case Western Reserve University, Cleveland, OH

  • University of California, San Francisco, San Francisco, CA

  • Centre hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada

  • 5D CLINICS, Claremont, Australia

  • Erasmus University Medical Center, Rotterdam, Netherlands

  • Grenoble Alpes University, Centre Hospitalier Universitaire de Grenoble, Grenoble, France

  • University of California, Los Angeles, Los Angeles, CA

  • Hospital Universitario La Paz, Madrid, Spain

  • McGill University Health Centre, Montreal, QC, Canada

  • Rush University Medical Center, Chicago, IL

  • Washington University School of Medicine, St. Louis, MO

  • Erasmus Medical Center Cancer Institute, Rotterdam, Netherlands

  • Hôpital La Salpêtrière, Paris, France

  • Medical Research Council, London, UT, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Calvary Mater Newcastle, Waratah, NSW, Australia

  • University Hospitals Cleveland Medical Center / Case Western Reserve University School of Medicine, Cleveland, OH

  • University of Newcastle, Newcastle, New South Wales, Australia

Locations

  • Netherlands

  • France

  • Canada

  • Spain

  • Australia

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved